ClinicalTrials.gg
CompletedNCT05152342Updated May 16, 2024

Reducing Stigma Among Individuals With Addiction and Staff in the Criminal Justice System

An interventional study of Stigma Awareness Training for Legal System Staff and Acceptance and Commitment Therapy for self-stigma in Stigma, Social and Behavior, sponsored by East Tennessee State University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-16.

Sponsored by East Tennessee State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

Stigma is one of the most pervasive barriers to addiction care in the U.S. criminal justice (CJ) system. However, there have been no stigma reduction interventions developed for this context. This project addresses this gap with a new multi-level stigma intervention, Combatting Stigma to Aid Reentry and Recovery (CSTARR), for justice-involved people with addiction and criminal justice staff. This intervention will be implemented in 6 (mostly rural) counties in TN for clients and staff in the Tennessee Recovery Oriented Compliance Strategy (TN-ROCS) program, which coordinates multiple CJ sectors (i.e., courts, corrections, probation, treatment) to divert and treat people with addiction. This project aims to 1) examine the feasibility, acceptability, and implementation considerations of integrating CSTARR in the TN-ROCS program, and 2) determine whether CSTARR impacts individual, staff, and program-level outcomes. We aim to recruit 25 stakeholders, 80 clients, and 75 staff over the course of this 18-month project to participate in our intervention and evaluation efforts. Staff and clients will be asked to complete online surveys before and after the intervention, as well as 1- and 3-month follow ups, for which they will receive gift-cards. The overall goal of this project is to examine the feasibility and utility of stigma reduction efforts in the criminal justice system to determine whether they can help facilitate engagement with evidence-based addiction care and improve client and staff outcomes.

Read the detailed description

Stigma is one of the most pervasive barriers to addiction care in the U.S. criminal justice (CJ) system. Stigmatizing attitudes about addiction, its intersecting conditions (i.e., criminal involvement), and its treatment (i.e., medications for opioid use disorder [MOUD]) are widespread throughout court, corrections, probation, and treatment sectors. These attitudes impact treatment decisions as well as how staff interact with clients. CJ-involved individuals with addiction are aware of this stigma, perceiving negative stereotypes, expecting to be judged, and often feeling ashamed and worthless as a result (i.e., self-stigma). Self-stigma is a robust predictor of treatment avoidance, non-compliance, and dropout in many stigmatized groups, including people with addiction and CJ involvement, making this a critical treatment barrier. Despite the negative consequences of stigma in the CJ system, there are virtually no stigma reduction interventions in this context. Given that the CJ system provides a substantial portion of addiction treatment, and untreated addiction increases risk for relapse, re-arrest, overdose, and other negative outcomes, it is essential to address stigma-related barriers to addiction care.

We drew from existing evidence-based interventions to develop a multi-level stigma intervention, Combatting Stigma to Aid Re-entry and Recovery (CSTARR), that simultaneously targets CJ staff attitudes as well as CJ-involved individuals' ability to cope with stigma in separate client and staff interventions. The staff intervention involves a half-day Stigma Awareness Training, and the client intervention involves a three-session Acceptance and Commitment Therapy for self-stigma group that was adapted to address criminal involvement in addition to addiction stigma. We will deliver both interventions virtually in 6 (primarily rural) Tennessee counties that contain infrastructure called the Tennessee Recovery Oriented Compliance Strategy (TN-ROCS). TN-ROCS coordinates multiple CJ sectors (i.e., courts, corrections, probation, treatment) to divert and treat people with addiction, thus presenting a unique unified system to intervene with stigma at both client and staff levels. Also, select TN-ROCS counties are integrating MOUD services, providing an opportunity to reduce stigma that may ultimately impact MOUD engagement. This project aims to 1) examine the feasibility, acceptability, and implementation considerations of integrating CSTARR in the TN-ROCS program, and 2) determine whether CSTARR impacts individual, staff, and program-level outcomes.

We aim to recruit 25 stakeholders, 80 clients, and 75 staff over the course of this 18-month project to participate in our intervention and evaluation efforts. Staff and clients will be asked to complete online surveys before and after the intervention, as well as 1- and 3-month follow ups, for which they will receive gift-cards. The overall goal of this project is to examine the feasibility and utility of stigma reduction efforts in the criminal justice system to determine whether they can help facilitate engagement with evidence-based addiction care and improve client and staff outcomes.

02

Conditions studied

  • Stigma, Social
  • Behavior

Keywords

  • stigma reduction
  • substance use disorder
  • criminal involvement
03

In context

Social Stigma

266 studies on the registry are indexed under Social Stigma; 66 are open to participants now.

This study's enrollment of 110 is below the median of 139 across 217 interventional studies indexed under Social Stigma.

Browse Social Stigma studies →

Lead sponsor

East Tennessee State University is the lead sponsor of 21 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Any legal system staff (e.g., judges, attorneys, probation officers, treatment staff, support staff) who work with the Tennessee Recovery Oriented Compliance Strategy (TN-ROCS) program in Sullivan, Jefferson, Grainger, Sevier, Monroe, and McMinn counties are eligible to participate in the staff training.
  • Clients who have been accepted into the Tennessee Recovery Oriented Compliance Strategy (TN-ROCS) program in Sullivan, Jefferson, Grainger, Sevier, Monroe, and McMinn counties are eligible to participate in the staff training.

Exclusion criteria

Exclusion Criteria:

  • Staff who have not had contact with TN-ROCS clients in the past 90 days are not eligible.
  • Clients who are not accepted into the TN-ROCS program, or who become re-incarcerated are not eligible to participate.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
110 participants (actual)

Study arms

  • Experimental
    Staff intervention

    Half day virtual training for staff focusing on stigma reduction strategies.

    Behavioral: Stigma Awareness Training for Legal System Staff

  • Experimental
    Client intervention

    Three session virtual therapy group for clients focusing on behavioral strategies to cope with stigma.

    Behavioral: Acceptance and Commitment Therapy for self-stigma

Interventions

  • BehavioralStigma Awareness Training for Legal System Staff

    Multilevel intervention package addressing stigma associated with substance use and criminal involvement for staff and justice-involved clients enrolled in a diversion treatment program.

  • BehavioralAcceptance and Commitment Therapy for self-stigma

    Multilevel intervention package addressing stigma associated with substance use and criminal involvement for staff and justice-involved clients enrolled in a diversion treatment program.

06

What researchers measure

Primary outcomes

  1. Change in Perspectives on Stigma Reduction from Baseline to 3 month follow-up (staff)

    24-item internally developed measure that assesses perspectives on stigma and use of stigma reduction strategies among staff, total score ranges from 24 to 216 with higher scores indicating more positive views

    Time frame: Baseline, 1-day, 1-month, 3-months

  2. Change in Social Distance Scale from Baseline to 3 month follow-up (staff)

    5-item adapted measure that assesses desired social distance from people with a criminal and addiction history, total score ranges from 5-25 with higher scores indicating less desired social distance

    Time frame: Baseline, 1-day, 1-month, 3-months

  3. Change in Difference and Disdain Scale from Baseline to 3 month follow-up (staff)

    9-item adapted measure that assesses how staff view people who have substance use problems and criminal involvement, total score ranges from 9-81 with higher scores indicating more differences/disdain

    Time frame: Baseline, 1-day, 1-month, 3-months

  4. Change in Substance Use Self-Stigma Scale from Baseline to 3 month follow-up (client)

    41-item measure that assess how clients view themselves because of their criminal involvement and substance use problems, total score ranges from 41 to 205 with higher scores indicating more self-stigma

    Time frame: Baseline, 1-day, 1-month, 3-months

  5. Change in Internalized Shame Scale from Baseline to 3 month follow-up (client)

    24-item measures that assesses internalized shame, total score ranges from 40-120, with higher scores indicating more internalized shame

    Time frame: Baseline, 1-day, 1-month, 3-months

  6. Change in Self-efficacy from Baseline to 3 month follow-up (client)

    4-item measure that assesses clients' self-efficacy for navigating stigma stressors, total score ranges from 4-40 with higher scores indicating more self-efficacy

    Time frame: Baseline, 1-day, 1-month, 3-months

Secondary outcomes

  1. Change in Attitudes Toward Prisoners Scale from Baseline to 3 month follow-up (staff)

    36-item measure that assesses attitudes, beliefs, and negative stereotypes about people with criminal involvement, total score ranges from 36 to 180 with high scores indicating more stigmatizing attitudes

    Time frame: Baseline, 1-day, 1-month, 3-months

  2. Change in Dual-Relationship Inventory from Baseline to 3 month follow-up (staff)

    9-item measure that assesses how staff view and treat the justice-involved people they oversee, total scores range from 9 to 63 with higher scores indicating better relationships

    Time frame: Baseline, 1-day, 1-month, 3-months

  3. Change in Treatment Experiences Scale from Baseline to 3 month follow-up (client) from Baseline to 3 month follow-up (client)

    13-item adapted measure that assesses how clients feel about their ability to complete treatment, total scores range from 13 to 130 with higher scores indicating more confidence in treatment

    Time frame: Baseline, 1-day, 1-month, 3-months

  4. Change in Dual-Relationship Inventory from Baseline to 3 month follow-up (client)

    9-item adapted measure that assesses how justice-involved clients feel staff view and treat them, total scores range from 9 to 63 with higher scores indicating better relationships

    Time frame: Baseline, 1-day, 1-month, 3-months

Other outcomes

  1. Implementation outcome (staff)

    12-item internally developed measure that assesses how appropriate, useful, and relevant the stigma training is, total scores range from 12 to 60 with higher scores indicating more acceptability

    Time frame: 1-day

  2. Implementation outcome (client)

    12-item internally developed measure that assesses how appropriate, useful, and relevant the stigma group is, total scores range from 12 to 60 with higher scores indicating more acceptability

    Time frame: 1-day

07

Study locations

1 site
  • East Tennessee State University
    Johnson City, Tennessee 37614, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2021 to primary completion in Dec 2023, 27 months.

Of 162 non-industry interventional studies with no phase under Social Stigma, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's 27 months is above that.

Counting every sponsor, half of 164 studies reached it within 15 months; a quarter within 5 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2021
First posted
Dec 9, 2021
StartActual
Sep 30, 2021
Primary completionActual
Dec 30, 2023
CompletionActual
Dec 30, 2023
Last update
May 16, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05152342
Lead sponsor
East Tennessee State University
Responsible party
Kelly E. Moore (Schirr) (Assistant Professor, East Tennessee State University) — Principal investigator
First posted
Dec 9, 2021
Start date
Sep 30, 2021
Primary completion
Dec 30, 2023
Completion
Dec 30, 2023
Last update
May 16, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion